跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14,848 条关于
“Korea Otsuka Pharmaceutical”
全部
14,848
临床试验
1,429
药物
1,712
机构
2,249
资讯
9,458
7个月前
Otsuka Pharmaceutical Secures Exclusive Rights to Sky Labs' Cuffless Blood Pressure Monitor for Japan Market
去年
Otsuka Pharmaceutical Acquires Cantargia's CAN10 Antibody Program for $33 Million Upfront in Autoimmune Disease Deal
去年
Otsuka Pharmaceutical Secures Global Rights to HBM7020 BCMAxCD3 Bispecific T-Cell Engager for Autoimmune Diseases
去年
Otsuka Pharmaceutical Challenges Vera Therapeutics in Kidney Disease Race as GLP-1 Drugs Face Eye Safety Scrutiny
去年
Kuhnil Pharmaceutical Launches First Pediatric Insomnia Drug in Korea
9个月前
LENZ Therapeutics and Lotus Pharmaceutical Submit VIZZ for Presbyopia Treatment Approval in South Korea
12年前
South Korea Emerges as Premier Clinical Trial Hub with $20 Billion Pharmaceutical Market Potential
去年
Vertex and Ono Pharmaceutical Form Strategic Alliance for Povetacicept Development in Japan and South Korea
去年
Otsuka's Sibeprenlimab Shows Positive Phase 3 Interim Results for IgA Nephropathy
9个月前
Otsuka Submits FDA Application for First-in-Class ADHD Drug Centanafadine
第 1 页，共 946 页
上一页
下一页
